G01N 2333/54
Interleukins [il]
Official title: Interleukins [IL]
G01N2333/54 (Interleukins [il]) appears on 635 US grants and 1,465 published applications in this corpus.
Search patents in G01N- Granted patents
- 635
- Published applications
- 1,465
- Assignees
- 791
- Inventors
- 2,923
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 10 |
| 2003 | 1 | 23 |
| 2004 | 3 | 12 |
| 2005 | 9 | 34 |
| 2006 | 4 | 18 |
| 2007 | 9 | 24 |
| 2008 | 11 | 32 |
| 2009 | 9 | 35 |
| 2010 | 16 | 46 |
| 2011 | 18 | 55 |
| 2012 | 20 | 55 |
| 2013 | 23 | 44 |
| 2014 | 32 | 64 |
| 2015 | 33 | 86 |
| 2016 | 29 | 98 |
| 2017 | 45 | 88 |
| 2018 | 54 | 75 |
| 2019 | 45 | 80 |
| 2020 | 47 | 87 |
| 2021 | 39 | 82 |
| 2022 | 36 | 85 |
| 2023 | 29 | 89 |
| 2024 | 33 | 82 |
| 2025 | 40 | 84 |
| 2026 | 31 | 76 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/5412Il-6Indexing code164
- G01N 2333/545Il-1Indexing code109
- G01N 2333/5421Il-8Indexing code77
- G01N 2333/55Il-2Indexing code71
- G01N 2333/5428Il-10Indexing code61
- G01N 2333/5406Il-4Indexing code42
- G01N 2333/5437Il-13Indexing code34
- G01N 2333/5434Il-12Indexing code30
All 17 subgroupsShow fewer
- G01N 2333/5409Il-5Indexing code28
- G01N 2333/5443Il-15Indexing code24
- G01N 2333/5418Il-7Indexing code22
- G01N 2333/5403Il-3Indexing code10
- G01N 2333/5415Leukaemia inhibitory factor [lif]Indexing code5
- G01N 2333/5425Il-9Indexing code5
- G01N 2333/5446Il-16Indexing code5
- G01N 2333/5431Il-11Indexing code1
- G01N 2333/544Il-14Indexing code1
Recent patents
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- Equine multiplex health information panel22 Sep 2026US 12,742,788 B1Boundless Diagnostics Inc
- Controlled release of antibodies to modulate cytokines8 Sep 2026US 12,729,237 B2Flow Pharma, Inc.
- Method for classifying an allergic patient as eligible to allergen immunotherapy8 Sep 2026US 12,730,114 B2Stallergenes Greer International AG
- Method of treating ichthyosis in a subject by administering an anti-interleukin 36 receptor (IL-36R) binding agent25 Aug 2026US 12,715,924 B2AnaptysBio, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Selective glucocorticoid receptor modifiers for treating impaired skin wound healing1 Oct 2026US 2026/0294918 A1Akribes Biomedical GmbH
- Anti il-11 antibody1 Oct 2026US 2026/0297176 A1
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Antibodies to human programmed death receptor PD-1454US 8,354,509 B2MSD Oss B.V. · 2013
- Protein detection via nanoreporters166US 9,714,937 B2NanoString Technologies, Inc. · 2017
- Antibodies to human programmed death receptor PD-1151US 8,900,587 B2Merck Sharp & Dohme Corp. · 2014
- Methods and apparatus for conducting multiple measurements on a sample125US 7,858,321 B2Meso Scale Technologies, LLC. · 2010